Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check6 days agoChange DetectedMedlinePlus-related topic link text for rheumatoid arthritis and genetics was removed from the study record’s resource links.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the upadacitinib rheumatoid arthritis study, including its study details, results, locations, and supporting documents.SummaryDifference90%

- Check20 days agoChange DetectedThe ClinicalTrials.gov page still displays a 403 Forbidden error instead of the study record. The footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces that NIH is transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.